FDA clears guide wire for patients with peripheral artery disease

The FDA cleared a new guide wire from Cardiovascular Systems, Inc. on July 6 for use in the company’s peripheral orbital atherectomy systems.

The ViperWire Advance Peripheral Guide Wire with Flex Tip reduces the tip stiffness while maintaining torque transfer, according to a company news release. It also improves trackability and features a Nitinol support coil and larger proximal core.

The systems are used in patients with peripheral artery disease, which affects nearly 18 million adults in the U.S. Cardiovascular Systems, Inc. plans on releasing the new guide wire in August.